Haemonetics HAE EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Haemonetics’s reported figures.
The official record: Haemonetics’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Haemonetics's EBITDA?
- Haemonetics (HAE) reported EBITDA of $94.78M in Q4 2025.
- How has Haemonetics's EBITDA changed year-over-year?
- Haemonetics's EBITDA increased by 7.6% year-over-year, from $88.05M to $94.78M.
- What is the long-term trend for Haemonetics's EBITDA?
- Over 3 years (2022 to 2025), Haemonetics's EBITDA has grown at a 23.6% compound annual growth rate (CAGR), from $178.5M to $337.4M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.